Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1300 of 2228 entries
View as:

Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01191944 Org: User:
Start: 08/31/10 End: 01/31/12 Due: 01/31/13

Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02248883 Org: User:
Start: 12/31/05 End: - Due: -

Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection

Phase: N/A Priority: Normal
NCT ID: NCT01483625 Org: User:
Start: 11/30/11 End: 12/31/12 Due: 12/31/13

Metabolism and Pharmacokinetics of [14C]-BI 44370 BS Administered as an Oral Solution in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02215772 Org: User:
Start: 09/30/08 End: - Due: -

Multiple Oral Doses of BIBR 1048 MS Solution in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02170831 Org: User:
Start: 05/31/99 End: - Due: -

Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01316419 Org: User:
Start: 03/31/11 End: 06/30/14 Due: 06/30/15

Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02170636 Org: User:
Start: 01/31/02 End: - Due: -

BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT03771885 Org: User:
Start: 03/16/19 End: 01/07/20 Due: 01/07/21

Post Marketing Surveillance Study of Sifrol® in Patients With Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02248181 Org: User:
Start: 02/29/04 End: - Due: -

Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823

Phase: N/A Priority: Normal
NCT ID: NCT01189175 Org: User:
Start: 08/31/10 End: - Due: -

Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 163538 XX

Phase: N/A Priority: Normal
NCT ID: NCT01587391 Org: User:
Start: 04/30/12 End: 10/31/12 Due: 10/31/13

Safety, Tolerability, and Pharmacokinetics of a Subcutaneous and Intravenous Dose of BI 655130 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03100903 Org: User:
Start: 04/24/17 End: 01/10/18 Due: 01/10/19

Japanese IP-TN Trial

Phase: N/A Priority: Normal
NCT ID: NCT02831569 Org: User:
Start: 07/27/16 End: 10/19/16 Due: 10/19/17

Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02253797 Org: User:
Start: 07/31/03 End: - Due: -

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00239421 Org: User:
Start: 11/30/03 End: 09/30/04 Due: 09/30/05

A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04445090 Org: User:
Start: 07/21/20 End: 09/10/21 Due: 09/10/22

An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease

Phase: N/A Priority: Normal
NCT ID: NCT00002166 Org: User:
Start: - End: - Due: -

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of BI 11634 Oral Solution in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02214940 Org: User:
Start: 06/30/07 End: - Due: -

Postmarketing Surveillance Study of Atrovent® Inhaletten® in Chronic Obstructive Airways Disease

Phase: N/A Priority: Normal
NCT ID: NCT02238145 Org: User:
Start: 01/31/99 End: - Due: -

Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00659607 Org: User:
Start: 09/30/03 End: - Due: -

Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02183571 Org: User:
Start: 02/28/09 End: - Due: -

Metabolism and Pharmacokinetics of [14C]-BI 409306 After Administration as Oral Solution in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02597998 Org: User:
Start: 09/15/15 End: 12/11/15 Due: 12/11/16

Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort

Phase: N/A Priority: Normal
NCT ID: NCT02242292 Org: User:
Start: 04/30/06 End: - Due: -

BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01938846 Org: User:
Start: 09/05/13 End: 06/22/17 Due: 06/22/18

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)

Phase: N/A Priority: Normal
NCT ID: NCT00000649 Org: User:
Start: - End: - Due: -